PrimeRFP SCOUT · Federal Contract Recompete Brief

75F40125P00216FFP SOLE SOURCE AWARD 24-month — Lovelace Biomedical Research Institute

Lovelace Biomedical Research Institute holds $30.2M across 54 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 1 related award in the incumbent pipeline. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Sep 29, 2027 PoP end — agencies typically plan 12–18 months ahead.

Fda Office Of Acq Grant Svcs

Awarding office

Lovelace Biomedical Research Institute

Recipient

Sep 29, 2027

PoP end

$7.1M

Obligated

$7.1M

Potential

541380

NAICS

B529

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Lovelace Biomedical Research Institute — $90

Contract facts

NONE

Contract number75F40125P00216

AgencyFda Office Of Acq Grant Svcs

Awarding officeFda Office Of Acq Grant Svcs

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentLovelace Biomedical Research Institute

CAGE3MMH4

UEIMBT9RXJJ7428

NAICS541380

No full NAICS 541380 intel page yet. Browse NAICS intelligence

PSCB529

Place of performanceALBUQUERQUE NM

Pricing typeFirm Fixed Price

Extent competedNot Competed

Related solicitation75F40125Q00346

PoP startSep 19, 2025

PoP end (current)Sep 29, 2027

Obligated$7.1M

Current value$7.1M

Potential value$7.1M

SOLE SOURCE AWARD OF A 24-MONTH PERIOD, FIRM FIXED PRICE (FFP), ENDS TOXICOLOGICAL STUDIES FOR CENTER FOR TOBACCO PRODUCTS (CTP). is a federal NONE award for Fda Office Of Acq Grant Svcs held by Lovelace Biomedical Research Institute. Estimated value $7.1M ($7.1M obligated). Current period of performance ends Sep 29, 2027. Last award drew 1 bidder. Place of performance: ALBUQUERQUE NM. Related solicitation 75F40125Q00346.

SOLE SOURCE AWARD OF A 24-MONTH PERIOD, FIRM FIXED PRICE (FFP), ENDS TOXICOLOGICAL STUDIES FOR CENTER FOR TOBACCO PRODUCTS (CTP).

Recompete timing

Public

● Expiring in 405 days

Current PoP ends Sep 29, 2027 (405 days remaining). Agencies typically plan 12–18 months ahead — position before the PoP clock runs out.

Incumbent footprint

Public record

Lovelace Biomedical Research Institute — $30.2M obligated across 54 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($30.2M) · all agencies

Department of Health and Human Services (HHS)$29.7M · 98%Department of Defense (DOD)$486K · 2%

Open full company profile →

Related awards

Same incumbent

W81XWH22P0157

LICENSE AND MAINTENANCE SUPPORT, ON-SITE SUPPORT SERVICES FOR VSP WRAIR.

$742K

Sep 22, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75F40125P00216?

75F40125P00216 (FFP SOLE SOURCE AWARD 24-month) is a Fda Office Of Acq Grant Svcs award with a potential value of $7.1M, currently held by Lovelace Biomedical Research Institute. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75F40125P00216?

Fda Office Of Acq Grant Svcs awarded 75F40125P00216 to Lovelace Biomedical Research Institute (potential $7.1M).

Who is the incumbent on 75F40125P00216?

Lovelace Biomedical Research Institute is the incumbent with $30.2M across 54 related awards in SCOUT’s public footprint. The current period of performance ends Sep 29, 2027.

When does Lovelace Biomedical Research Institute’s 75F40125P00216 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 29, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 25, 2026 · refreshed monthlyLatest procurement action Sep 19, 2025